What medications are used to treat dry mouth (xerostomia)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Dry Mouth (Xerostomia)

For dry mouth treatment, a stepwise approach based on salivary gland function severity is recommended, starting with non-pharmacological methods for mild dysfunction, progressing to pharmacological stimulants for moderate dysfunction, and using saliva substitutes for severe cases with no salivary output. 1, 2

Assessment Before Treatment

  • Baseline evaluation of salivary gland function by measuring whole salivary flows is recommended before starting treatment 1, 3
  • Rule out conditions unrelated to salivary dysfunction such as candidiasis or burning mouth syndrome 1
  • Classify severity as mild (G1), moderate (G2), or severe (G3) based on symptoms and impact on daily life 3

Treatment Algorithm Based on Severity

First-Line: Non-Pharmacological Approaches (Mild Dysfunction)

  • Increase water intake and limit caffeine consumption which can worsen dry mouth symptoms 2
  • Use gustatory stimulants such as sugar-free acidic candies, lozenges, or xylitol 1, 2
  • Employ mechanical stimulants like sugar-free chewing gum to stimulate saliva production 1, 2
  • Implement dietary modifications by avoiding crunchy, spicy, acidic, or hot foods that may exacerbate discomfort 1, 2

Second-Line: Pharmacological Stimulation (Moderate Dysfunction)

  • Muscarinic agonists such as pilocarpine and cevimeline are FDA-approved for treating dry mouth 1, 4
  • Pilocarpine is indicated for dry mouth from salivary gland hypofunction caused by radiotherapy for head and neck cancer and for Sjögren's Syndrome 4
  • Recommended dosage for pilocarpine is 5 mg three times daily, which can be increased to 10 mg three times daily if needed 4
  • Cevimeline may have a better tolerance profile than pilocarpine 1, 5

Third-Line: Saliva Substitution (Severe Dysfunction/No Salivary Output)

  • Saliva substitutes should be the preferred approach for patients with no salivary output 1, 2
  • Use products with neutral pH containing fluoride and electrolytes to mimic natural saliva 2, 3
  • Available as oral sprays, gels, and rinses 1, 6

Efficacy and Side Effects

  • Pilocarpine significantly improves global assessment of dry mouth and specific symptoms like mouth discomfort and ability to speak without water 4
  • In clinical trials, pilocarpine increased salivary flow rates 2-10 fold higher than placebo 7
  • Common side effects of pilocarpine include sweating, nausea, rhinitis, diarrhea, chills, flushing, urinary frequency, dizziness, and asthenia 4, 8
  • Sweating is the most common adverse effect causing treatment discontinuation (≤1% at 5 mg TID; 12% at 10 mg TID) 4

Special Considerations

  • For cancer patients receiving immunotherapy who develop dry mouth, specific management guidelines for immunotherapy-related sicca syndrome should be followed 1
  • Severe sicca syndrome, if left untreated, can result in dental caries and eventually tooth loss 1, 6
  • Elderly patients are at higher risk of xerostomia due to increased medication use and polypharmacy 5, 6
  • Pharmacological stimulants require careful monitoring in older adults due to potential side effects 2, 5

Monitoring and Follow-up

  • Dental referral is recommended for patients with signs of dental complications from chronic dry mouth 1, 6
  • Rheumatology referral may be beneficial, especially for patients with suspected Sjögren's syndrome 1
  • Consider dose adjustments based on patient response and tolerability 4, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Managing Dry Mouth Caused by Vyvanse (Lisdexamfetamine)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Dry Mouth with Saliva Substitute Oral Sprays

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.